Why the study?
Does monthly vascular access blood flow (Qa) surveillance plus standard surveillance improve time to graft thrombosis and graft loss compared to standard surveillance alone?
Does monthly vascular access blood flow (Qa) surveillance plus standard surveillance improve time to graft thrombosis and graft loss compared to standard surveillance alone?
Regular vascular access blood flow surveillance increases the detection of stenosis and subsequent interventions but fails to improve time to graft thrombosis or graft loss compared to standard surveillance.
No takes yet. Share an insight, caveat, or question.
Qa surveillance adds interventions without improving graft survival; challenges routine adoption and confirms standard surveillance suffices.
Moist et al. (2003) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: